Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni Syndrome
Authors:
- 22 September 2020
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 115 (12) , 2095-2097
Abstract
INTRODUCTION: To assess the upper gastrointestinal (UGI) cancer risk and surveillance outcomes in Li-Fraumeni syndrome (LFS). METHODS: Analysis of the International Agency for Research on Cancer database and a single-center adult LFS cohort. RESULTS: UGI cancer was present in 7.2% of families and 3.9% of individuals with a pathogenic/likely pathogenic TP53 mutation in International Agency for Research on Cancer; 29% occurred before age 30. Our institutional cohort had 35 individuals (31% of the LFS cohort) with 48 cumulative upper endoscopies; 3 (8.5%) individuals had concerning UGI findings. DISCUSSION: UGI cancer is observed in LFS. Upper endoscopy should be part of a comprehensive LFS surveillance program.Keywords
This publication has 15 references indexed in Scilit:
- Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational studyThe Lancet Oncology, 2016
- TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics DataHuman Mutation, 2016
- Genomic variant annotation and prioritization with ANNOVAR and wANNOVARNature Protocols, 2015
- Revisiting Li-Fraumeni Syndrome From TP53 Mutation CarriersJournal of Clinical Oncology, 2015
- Surveillance recommendations for patients with germline TP53 mutationsCurrent Opinion in Oncology, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Li-Fraumeni syndrome: cancer risk assessment and clinical managementNature Reviews Clinical Oncology, 2014
- Gastric cancer in individuals with Li-Fraumeni syndromeGenetics in Medicine, 2011
- Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational studyThe Lancet Oncology, 2011
- Prevalence of Early Onset Colorectal Cancer in 397 Patients With Classic Li–Fraumeni SyndromeGastroenterology, 2006